Diana F. Florescu

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay et al. · New England Journal of Medicine · 2021 · 445 citations · Full text

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

Robin K. Avery, Sophie Alain, Barbara D. Alexander et al. · Clinical Infectious Diseases · 2021 · 277 citations · Full text

Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

Diana F. Florescu, Steven A. Pergam, Michael Neely et al. · Biology of Blood and Marrow Transplantation · 2011 · 174 citations · Full text

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

Diana F. Florescu, Megan Keck · Expert Review of Anti-infective Therapy · 2014 · 150 citations

Molecular Virology, Synthetic Virology, Pathogenesis +13

Is Bacteremic Sepsis Associated With Higher Mortality in Transplant Recipients Than in Nontransplant Patients? A Matched Case-Control Propensity-Adjusted Study

André C. Kalil, Ather Ahmed Syed, Mark E. Rupp et al. · Clinical Infectious Diseases · 2014 · 121 citations · Full text